cbdMD (YCBD) Shares Outstanding (2016 - 2025)
cbdMD (YCBD) reported Shares Outstanding (Entity) of $783355.0 for Q1 2025, up 105.79% on a YoY basis from $380650.0 in Q1 2024, and up 37.67% sequentially from $569008.0 in Q4 2024.
cbdMD (YCBD) Shares Outstanding (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 9 years of Shares Outstanding (Entity) data on file, last reported at $783355.0 in Q1 2025.
- For the quarter ending Q1 2025, Shares Outstanding (Entity) rose 105.79% year-over-year to $783355.0; the trailing twelve-month figure through Mar 2025 stood at $783355.0 (up 105.79% YoY), and the FY2024 full-year result was $492382.0, up 94.78% from the prior year.
- Shares Outstanding (Entity) improved to $783355.0 in Q1 2025, from $569008.0 in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $783355.0 in Q1 2025 to a low of $156478.0 in Q1 2021.
- A 5-year average of $303694.0 and a median of $182087.0 in 2023 frame the typical range for Shares Outstanding (Entity).
- Across the five-year window, Shares Outstanding (Entity) climbed 4.18% in 2022 and soared 119.5% in 2023, its largest moves.
- Tracing YCBD's Shares Outstanding (Entity) over 5 years: stood at $161867.0 in 2021, then gained by 4.18% to $168628.0 in 2022, then jumped by 119.5% to $370132.0 in 2023, then soared by 53.73% to $569008.0 in 2024, then soared by 37.67% to $783355.0 in 2025.
- Business Quant data shows YCBD's Shares Outstanding (Entity) at $783355.0 in Q1 2025, $569008.0 in Q4 2024, and $492382.0 in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 8.98 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 1.16 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 422.10 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.58 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.50 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 455,871.00 |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 100.50 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 497.70 Mn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 9.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 9.00 Mn |
| Sep 30, 2025 | 4.02 Mn |
| Jun 30, 2025 | 5.78 Mn |
| Mar 31, 2025 | 778,410.00 |
| Dec 31, 2024 | 569,008.00 |
| Sep 30, 2024 | 539,068.00 |
| Jun 30, 2024 | 449,121.00 |
| Mar 31, 2024 | 370,132.00 |
| Dec 31, 2023 | 370,118.00 |
| Sep 30, 2023 | 252,790.00 |
| Jun 30, 2023 | 297,454.00 |
| Mar 31, 2023 | 168,199.00 |
| Dec 31, 2022 | 167,643.00 |
| Sep 30, 2022 | 165,956.00 |
| Jun 30, 2022 | 164,752.00 |
| Mar 31, 2022 | 163,781.00 |
| Dec 31, 2021 | 160,610.00 |
| Sep 30, 2021 | 152,591.00 |
| Jun 30, 2021 | 157,418.00 |
| Mar 31, 2021 | 148,517.00 |